Stay updated with breaking news from Andrew Moin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sioux Falls, SD , March 29, 2024 -- SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results March 29, 2024 SAB-142 Phase 1 trial on track for data release during 2024 ...
SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results March 29, 2024 SAB-142 Phase 1 trial on track for data release during 2024 ...
SAB also announces closing of $7.5 million financing, the first tranche of $130 million private placementSIOUX FALLS, S.D., Oct. 05, 2023 -- SAB Biotherapeutics ; class='js-l-obf link...
Funding to support clinical advancement of SAB-142, a potential disease-modifying treatment Financing led by RA Capital Management, with participation from BVF Partners, Sessa Capital, Commodore...